Teyi Pharmaceutical Group Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001WK6
CNY
10.27
0.2 (1.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
209.87
232.68
200.71
196.01
295.13
232.19
141.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
209.87
232.68
200.71
196.01
295.13
232.19
141.85
Raw Material Cost
81.88
129.21
110.19
98.56
111.46
114.34
96.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.78
0.58
0.58
1.22
1.85
1.32
0.64
Selling and Distribution Expenses
84.18
76.98
55.73
78.71
131.79
75.80
34.03
Other Expenses
0.85
1.27
0.96
0.75
0.68
0.73
1.06
Total Expenditure (Excl Depreciation)
175.31
219.49
176.09
186.00
251.86
198.75
141.60
Operating Profit (PBDIT) excl Other Income
34.6
13.200000000000001
24.6
10
43.3
33.4
0.2
Other Income
2.77
1.33
5.34
2.01
2.34
3.30
3.09
Operating Profit (PBDIT)
35.91
25.35
44.68
27.21
58.61
37.28
17.84
Interest
0.78
0.58
0.58
1.22
1.85
1.32
0.64
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
127.99
103.47
90.52
97.45
183.67
117.85
45.55
Depreciation
0.00
17.32
17.32
17.35
17.35
16.10
16.10
Profit Before Tax
35.14
7.45
26.78
8.64
39.42
19.86
1.10
Tax
9.37
-9.00
-0.43
2.20
7.85
5.37
-2.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.76
16.45
27.21
6.44
31.57
14.49
3.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.76
16.45
27.21
6.44
31.57
14.49
3.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
25.76
16.45
27.21
6.44
31.57
14.49
3.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,847.28
1,821.47
1,802.94
1,773.41
1,798.48
1,764.93
1,741.59
Earnings per share (EPS)
0.05
0.03
0.05
0.01
0.06
0.03
0.01
Diluted Earnings per share
0.05
0.03
0.05
0.01
0.06
0.03
0.01
Operating Profit Margin (Excl OI)
15.79%
2.88%
10.97%
4.01%
13.19%
7.7%
-0.96%
Gross Profit Margin
16.74%
10.65%
21.97%
13.26%
19.23%
15.49%
12.13%
PAT Margin
12.28%
7.07%
13.56%
3.29%
10.7%
6.24%
2.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is -28.87% vs 79.28% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -18.35% vs 243.48% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -41.21% vs 133.61% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -57.89% vs 35.71% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Teyi Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
209.87
0
209.87
Other Operating Income
0.00
0.00
0.00
Total Operating income
209.87
0
209.87
Raw Material Cost
81.88
0
81.88
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.78
0
0.78
Selling and Distribution Expenses
84.18
0
84.18
Other Expenses
0.85
0.00
0.85
Total Expenditure (Excl Depreciation)
175.31
0
175.31
Operating Profit (PBDIT) excl Other Income
34.56
0.00
34.56
Other Income
2.77
0
2.77
Operating Profit (PBDIT)
35.91
0
35.91
Interest
0.78
0
0.78
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
127.99
0
127.99
Depreciation
0.00
0
0.00
Profit Before Tax
35.14
0
35.14
Tax
9.37
0
9.37
Provisions and contingencies
0
0
0.00
Profit After Tax
25.76
0
25.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
25.76
0
25.76
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
25.76
0
25.76
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,847.28
0
1,847.28
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
15.79%
0%
0.00
15.79%
Gross Profit Margin
16.74%
0%
0.00
16.74%
PAT Margin
12.28%
0%
0.00
12.28%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 20.99 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -9.80% vs 15.94% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -28.87% vs 79.28% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.58 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 56.36% vs -39.34% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -18.35% vs 243.48% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.31 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 37.92% vs -38.93% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -41.21% vs 133.61% in Mar 2025

Quarterly - Interest
Interest 0.08 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 33.33% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -57.89% vs 35.71% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.79%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025